In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CNS Breathe Right Nasal Strips Repackaged To Stress Congestion Relief

This article was originally published in The Tan Sheet

Executive Summary

CNS is repackaging its line of Breathe Right nasal strips to emphasize their use for the relief of nasal congestion; the products primarily have been marketed as sleep and snoring aids and for improved nasal breathing.

You may also be interested in...



CNS Breathe Right Strips Featuring Vicks Vapors Slated For Autumn Launch

Breathe Right nasal strips with Vicks mentholated vapors will be available this fall for the cough/cold season, CNS announced March 6. CNS' licensing agreement with Procter & Gamble includes the right to use the Vicks brand name and some joint promotions.

CNS Breathe Right Strips Featuring Vicks Vapors Slated For Autumn Launch

Breathe Right nasal strips with Vicks mentholated vapors will be available this fall for the cough/cold season, CNS announced March 6. CNS' licensing agreement with Procter & Gamble includes the right to use the Vicks brand name and some joint promotions.

CNS Breathe Right Strips Featuring Vicks Vapors Slated For Autumn Launch

Breathe Right nasal strips with Vicks mentholated vapors will be available this fall for the cough/cold season, CNS announced March 6. CNS' licensing agreement with Procter & Gamble includes the right to use the Vicks brand name and some joint promotions.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel